Approximately 62% of known SAVI patients harbor the V155M mutation, and ~86% of reported SAVI patients have mutations in the same region as V155M, highlighting a crucial area for eliciting STING activation20. The gene discussed is STING1; the disease is STING-associated vasculopathy with onset in infancy.